Health of Women Summit Brings Together Early-Stage Yale Research, Investors, and Industry Partners
On Wednesday, Oct 18th, amplifyHERscience hosted The Health of Women Summit at the Yale Divinity School. The full-day event focused on accelerating the translation of early-stage Yale research on women’s health. Eleven outstanding Yale researchers in this field were spotlighted for their groundbreaking work. The summit delved into several critical areas that disproportionately impact women, including oncology, autoimmune diseases, cardiovascular health, mental health, orthopedics and reproductive health. Importantly, the summit served as a platform to connect Yale researchers with industry experts and investors targeting women’s health, fostering collaboration and the exchange of valuable insights.
“At Yale Ventures and amplifyHERscience we are privileged to support our faculty working in women’s health through events like the Health of Women Summit to maximize the impact of their research in areas that have traditionally been underfunded, ignored or trivialized,” said Morag Grassie, Director of The Blavatnik Fund for Innovation at Yale. "The Summit brought together not only early-stage researchers from across Yale, but also investors and industry partners who can help to support the translation of healthcare research and innovation in women's health."
The event was attended by Yale faculty, research staff, and students who are interested in the health of women, and who seek to develop ventures focused on impact in this area. Additionally, the summit welcomed investors, biopharma companies who advanced the well-being of women, as well as research organizations and advocates in this sector.
The day's agenda featured engaging fireside chats, including one with Stephanie Kramer, the Chief Human Resources Officer of L'Oréal, who was interviewed by Pam Belluck, Health & Science writer for The New York Times. The summit also had a notable conversation with Marcel van Duin, Ph.D., Chief Scientific Officer at Organon. Presentations on Fundamental Science Research, a panel discussion “Excellence and Challenges in Research Exploring the Health of Women, and faculty research spotlights were also included.
The event was sponsored by Organon and Pabst Patent Group.
Presenters
Fundamental Science Presentations
Yingqun Huang: Treatment of Anorexia Nervosa Using a First-In-Class Small Molecule
Nina Stachenfeld: Reproductive hormone effects on the cardiovascular health of women
Samit Shah: Leaving No Stone Unturned: Changing the Way We Care for Women's Hearts
David Stitelman: Developmental defects in fetus - Spina bifida
Madhu Venkadesan: ACL injury
Faculty Research Spotlights
Gloria Huang: Precision Medicine for ARID1A mutated Ovarian and Uterine Cancers
Naiem Nassiri: Targeted Therapeutics: Standarizing the treatment for vascular malformations
Demetrios Braddock: Entelion: Novel enzyme therapy for lupus
Kevin Sheth: Alva Health: Faster stroke diagnosis for better outcomes
Clare Flannery: Endometrial cancer: role of metabolic diseases
Barbara Ehrlich: Osmol, Developing a first-in-class preventative treatment for Chemotherapy-Induced Neuropathy
Keynotes & Panels
Morning Keynote: Stephanie Kramer, Chief Human Resources Officer (CHRO) of L'Oréal USA
Interviewed by Pam Belluck, Health & Science writer, New York Times
Afternoon Keynote: Marcel van Duin, PhD, Chief Scientific Officer at Organon
Interviewed by Pam Belluck, Health & Science writer, New York Times
Panel Discussion
Excellence and Challenges in Research Exploring the Health of Women
